- Affordability: Are HTA, the CDF and AAR helping? Presented at BOPA Symposium 2016, 15 Oct 2016, Manchester £t
- Hot topics in market access, Presented at Pharma Mini MBA, Management Forum, 19 May 2016, London t
- The economics of orphan drugs, Presented at the Society for Endocrinology BES, 4 Nov 2015, Edinburgh £
- Market Access & How the Pharma Industry Can Engage with Emerging Stakeholders, Presented at Pharma Mini MBA, Management Forum, 9 Oct 2015, London t
- Britain Against Cancer 2015: Unlocking cancer drugs Debate, 11 Dec 2015, London. See what Wellards had to say about the debate
- Britain Against Cancer 2014: Access to Medicines Debate, 9 Dec 2014, London. See what Macmillan, Access CML Drugs and Breakthrough Breast Cancer had to say about the debate
- 'New' NHS in England - overview of the landscape Presented at the GUNA Summer Clinical Meeting - Shaping Best Practice 28 Jun 2013 London
- Health Economics and Cancer: The Cancer Drug's Fund and Value Based Pricing: What Lies Ahead? Presented at the British Society for Haematology, Glasgow, 16 Apr 2012 £
- The Place of Work in Healthcare Decision Making, Presented at Fit for Work Europe 3rd Annual Conference, Brussels, 19 Oct 2011 £
- Atrial Fibrillation in Europe: How AWARE are you? Presentation at AF AWARE Conference, Ljubljana, Slovenia, 25 Nov 2010 t
- Economics of organ donation, Debate “Organ donation: at what cost?” Human Tissue Authority Review of the Year London, 15 Jun 2010. See a video of the presentation too
- Risk-sharing Models for Innovative Reimbursement and How They Are Evolving in the UK, Presented at CBI Global Pricing and Market Access Strategies, 21 Jan 2010, Philadelphia t
- Productivity and the wider societal perspective in HTA: Beyond MSDs, Presented at HTAi 2009, 23 Jun 2009, Singapore £
- Use of Health Technology Assessments and Pharmacoeconomic Data Outside of the US, Presented at CBI 2nd Annual Bio/Pharmaceutical and Medical Device Forum on Effective Product Pricing and Modeling Strategies, 6 April 2009, Philadelphia t
- Healthy Work, Presentation for Launch of Healthy Work: Challenges and Opportunities to 2030, SMF, 31 March 2009 London
For transparency, those presentations with £ are presentations for which I received payment and t are presentations for which I did not receive payment but where my travel expenses (at standard class) were reimbursed. Where there is no symbol, I received no payment for the presentation and self-funded my travel expenses.
